The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...

Dawn Jackson Blatner, R.D.N., dietitian and certified specialist in sports nutrition; Janet Funk, M.S., M.D., F.A.C.P., is a ...

Poisoning caused by too much of the popular nutrient is rare, but cases are ticking up. Experts warn that people may not be ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

Don't wait too long to press the buy button on these comeback stories.

Kirstyn Hill has worked as a clinical pediatric and women’s health pharmacist since 2020. She was driven to work with a patient population that is not often able to easily speak up for themselves and ...

The popularity of GLP-1 weight-loss drugs has seen a seismic shift in just over a year. Not long ago, they were primarily used for diabetes. But now, that’s changing. In some markets, such as the US, ...

Kristie Reed, PharmD, oversees emergency, general medical, surgical, psychiatric care, and oncology medication as the pharmacy director of a community hospital. Dr. Reed specializes in IV medications.

Last month, the Trump administration announced major plans to slash prices of GLP-1s, including Ozempic, Wegovy, Zepbound, and Mounjaro. The agreement will lower prices of these medications from ...

As use of GLP-1 receptor agonists (RAs) continues to rise exponentially, awareness of its most common side effects, such as nausea and vomiting, is growing. But the drugs come with some lesser-known ...

Q. I was on a 14-day course of prednisone for vertigo. Once I stopped, I had terrible withdrawal symptoms that have persisted for more than 10 days. Luckily, they are getting better, but I’m still ...

A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are calling for more research. Reading time 2 minutes Every drug has its risks, no ...